These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21554446)

  • 1. A public-health approach to site-specific formulary management: addressing deficient drug supplies in Malawi.
    Lauffenburger JC; Jonkman LJ; Lange CE; Connor SE; Sibale C
    Int J Pharm Pract; 2011 Jun; 19(3):201-5. PubMed ID: 21554446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Drug Formulary Committee in a developing country.
    Fraser HS; Prescod L
    Hosp Formul; 1986 Sep; 21(9):957-9. PubMed ID: 10278614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive pharmaceutical services for a state correctional facility.
    Kingston RL; Pfeifle CE; Cipolle RJ; Zaske DE; Eells CB; Johnson HL
    Am J Hosp Pharm; 1982 Jan; 39(1):86-9. PubMed ID: 7055154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug formulary decision-making in two regional health authorities in British Columbia, Canada.
    Armstrong K; Mitton C; Carleton B; Shoveller J
    Health Policy; 2008 Dec; 88(2-3):308-16. PubMed ID: 18508151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential drugs in the Gambia.
    Jallow MT
    World Health Forum; 1993; 14(2):136-9. PubMed ID: 8185753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A proposed open formulary for a managed care program in Mexico. The Therapeutic and Pharmacological Committee of Mexico].
    Salud Publica Mex; 1999; 41(1):27-41. PubMed ID: 10081332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    J Healthc Resour Manag; 1996 Sep; 14(7):14-9. PubMed ID: 10161585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of follow-on drugs and indications on the WHO Essential Drug List.
    Cohen J; Cabanilla L; Sosnov J
    J Clin Pharm Ther; 2006 Dec; 31(6):585-92. PubMed ID: 17176363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'wise list'- a comprehensive model for drug and therapeutics committees to achieve adherence to recommendations for essential drugs among prescribers?
    Stichele RV
    Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):221-3. PubMed ID: 21414142
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes of physicians toward formularies and services provided by pharmacists.
    Sansgiry SS; Hayes JD; Rice GK
    Manag Care Interface; 2003 Feb; 16(2):34-8. PubMed ID: 12647524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug formulary commentary: an integrated health systems approach.
    Boyer ST
    Pharm Pract Manag Q; 1995 Oct; 15(3):83-5. PubMed ID: 10151716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of managed care drug formularies.
    Navarro RP
    Med Interface; 1994 Apr; 7(4):62-4. PubMed ID: 10133359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning a pharmacy-led medical mission trip, part 1: focus on medication acquisition.
    Brown DA; Ferrill MJ
    Ann Pharmacother; 2012 May; 46(5):751-9. PubMed ID: 22550274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
    Muula AS
    Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and pharmacy benefit management.
    Harris KM; Thomas C
    J Addict Dis; 2004; 23(4):11-29. PubMed ID: 15339711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the selection and use of essential medicines decrease inappropriate drug use?
    Reidenberg MM
    Clin Pharmacol Ther; 2009 Jun; 85(6):581-3. PubMed ID: 19451911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.